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PERCUTANEOUS ABSORPTION OF NICOTINIC ACID AND DERIVATIVES
RICHARD B. STOUGHTON, M.D.,* WILLIAM E. CLENDENNING, M.D.f AND
DORIS KRTJSE, B.S4
We have utilized a biologic reaction (vaso-
dilation) to measure penetration through the
epidermis of nicotinic acid and seven closely
related derivatives. We have also determined the
partition coefficients and the absolute solubiities
of these substances in water and ether. A correla-
tion is shown between the ease of percutaneous
absorption of a given compound and the absolute
and relative solubilities of these compounds in
ether and water.
Many technics have been devised for the
detection and measurement of percutaneous
absorption (1, 2). One of those which can be
used in vivo on human skin is the biologic method.
This depends upon the ability of a topically
applied substance to reach a specific structure
(blood vessel, gland, smooth muscle, etc.)
resulting in a reaction which can be measured or
visualized by surface observation. Vasodilation
and vasoconstriction are good examples of such
reactions and a variety of substances can induce
them. Thus, if a known compound such as
nicotinic acid is applied to the surface of the
skin and we observe erythema restricted to the
site of application, we surmise that the compound
has reached blood vessels in the corium.
In order to estimate how much of any com-
pound has penetrated it is necessary to know
how much of the substance is required to give
a minimal detectable reaction. This can be done
by intradermal injections of serial dilutions of
the compound under study until the minimal
concentration which will give a visible reaction
is determined.
Disadvantages of this method are twofold.
First, as with other methods, it is difficult to
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derive definite information regarding the route
of penetration. The initial presence or absence
of a follicular or perifollicular reaction pattern
may suggest a primarily transfollicular or trans-
epidermal route but is rarely conclusive. Second,
the reactivity of an individual subject often
varies somewhat from day to day and may depend
upon such variable factors as temperature,
humidity, season, and the psychic state.
We feel, however, that useful information
can be derived from the employment of this
method. The drawbacks would seem to be out-
weighed by the advantages of using an undis-
turbed in vivo system and the knowledge that
the development of a reaction to the substance
applied indicates with certainty that penetration
into the coriuni has taken place. Some agents are
biologically active in concentrations as dilute
as 10 which gives a very sensitive index for
quantitation. Furthermore, this method permits
investigation of regional differences in percu-
taneous absorption and allows one to attempt
correlation between these differences and the
anatomical structure of the region under study.
Walzer (3) utilized this method in showing
percutaneous absorption of antigens. First, a site
on the skin was passively sensitized. After 24 to
48 hours the antigen was rubbed in at another
site. The development of an urticarial reaction
in the sensitized area was considered evidence
that the antigen had entered the circulation. It
is questionable however whether the "barrier
area" was not damaged by the rather vigorous
method of inunction employed.
Shelley and Melton (4) inuncted acetylcholine
and piocarpine nitrate. They then detected
sweating by the starch paper-iodine method.
Atropine SO4 and Hyoscine hydrobromide were
effective topically in inhibiting sweating. A
concentrated (18%) aqueous solution of hyoscine
hydrobromide resulted in local anhidrosis which
persisted for weeks after the application (5).
The biologic effects of the application of hista-
mine were studied by these same workers (6).
Factors accelerating the penetration of histamine
such as the vehicle, the concentration, and the
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form of the active substance were determined.
It was found that the use of a cream as the
vehicle, increasing the concentration of the active
agent, and using free histamine base as opposed
to the salt, would all enhance absorption.
They then went one step further and evaluated
the effect of 54 topical antipruritic preparations
on intradermally-induced histamine pruritus
(7). None of the compounds tested had any
significant effect suggesting the relative imperme-
ability of normal skin to these agents.
Michelfelder and Peck (8) studied the absorp-
tion of pyribenzamine through both intact and
damaged skin by noting the effect of the inuncted
antthistaminic on intradermal injections of
histamine.
Monash (9) used the topical application of
local anesthetics (time required for anesthesia)
and histamine (appearance of the triple response)
in his work on the location of the superficial
"barrier area".
The penetration of adrenaline through the skin
has been studied by Nichols (10) using a method
quite similar to the one we have employed. Adren-
aline on intradermal injection produced con-
sistent blanching at concentrations of 10—6.
Creams with adrenaline incorporated at con-
centrations of 1:5000 and 1:100 did not elicit
visible reactions following inunction. It was
concluded that if adrenaline from a 1 in 5000 or
1 in 100 cream passed into the skin, it did so in
a concentration below 1 in 1,000,000.
Recently there have been a number of reports
on the response of normal and abnormal human
subjects to the inunction of tetrahydrofurfuryl
nicotinate (Trafuril, Ciba) (11, 12, 13). The
normal response is erythema and edema. Atopics
are abnormal in their response (either no reaction
or blanching) in 50 to 70% of those tested. There
is positive correlation between this abnormal
reaction to tetrahydrofurfural nicotinate and the
acetyicholine blanch phenomenon in many
cases. Approximately 70% of those with acute
rheumatic fever give the same abnormal reaction
as the atopic (12). Non-reactivity in uncontrolled
diabetes was the only abnormal response en-
countered in a recent series of patients with
diseases unrelated to acute rheumatic fever or
the atopic diathesis (13). While the percentage
of abnormal responses in these conditions is
high it would hardly seem of the magnitude to
warrant much enthusiasm for the use of tetra-
hydrofurfuryl as a diagnostic test.
Finally, a word should be said concerning
the probable mechanism of action of the nico-
tinates. Fulton, Farber, and Moreci (14) have
applied concentrated solutions of esters of nico-
tithe acid to the everted hamster cheek pouch.
No qualitative or quantitative differences were
noted with respect to the vasomotor effect
(dilation) among the esters studied (methyl,
ethyl, hexyl, tetrahydrofurfuryl). The charac-
teristics of this vasodilator response suggested
both a direct action of the nicotinate on the
vascular smooth muscle and mediation by a local
nerve conduction mechanism. It did not seem
likely that the responses initiated were dependent
upon tissue injury with resultant release of
histamine-like products.
PROCEDURE AND RESULTS
1. Intradermal Injection of Nicotinic Acid and
Derivatives
Procedure: Intradermal injections were done in
5 subjects. Serial dilutions (by a factor of 10 from
10-' to 10—10) in normal saline were employed. The
injections were made of the volar surface of the
forearm and on the back. .05 ml. of each dilution
was injected. Normal saline was used as the con-
trol. Detection of erythema greater than that pro-
duced by the saline injection was considered a
positive reaction.
Results: Nicotinie acid and the derivatives used
in this study were all approximately equal in
their ability to produce erythema following
intradermal injection. At the higher concentra-
tions employed, erythema persisted for several
hours following injection. Extremely dilute
solutions (10) of all the agents produced tran-
sient but definite erythema. Dilutions of 10-10
elicited no visible reaction from any of the series
(See Table I).
. Topical Application of Nicotinic Acid and
Derivatives
Procedure: Serial dilutions in 95% alcohol of
the compounds under study were applied to the
back and volar surface of the forearm of 5 sub-
jects. .01 ml. of each dilution was dropped on the
skin from a pipette and lightly spread over a cir-
cular area approximately 2 cm. in diameter by 3
rotary movements of the tip of the pipette. Care
was taken not to scratch or damage the superficial
epidermis. Minimal concentrations producing
visible erythema were considered the end-point.
Results: Table II gives the average mininial
concentration producing erythema on topical
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TABLE I
Intradermal injection in normal saline
(0.05 ml.)
10—' 1O—°. lO—
Nicotinic Acid ++ + 0
Nicotinic Acid UC1 ++ + 0
Methyl Nicotinate ++ + 0
Ethyl Nicotinate ++ + 0
Butyl Nicotinate ++ + 0
Hexyl Nicotinate ++ + 0
Octyl Nicotinate ++ + 0
Tetrahydrofurfuryl Nico-
tinate ++ + 0
* Minimal concentration giving erythema.
application. Erythema always appeared first
in the follicular and perifollicular areas at the
site of application. When higher concentrations
were employed erythema would become diffuse
but was always confined to the area of applica-
tion. At the dilutions given in the table as the
end-point, only follicular and perifollicular
erythema were noted. For ease in comparing
activity, a "penetration index" was derived for
each substance by division of the end-point
dilution of each nicotinate by the end-point
dilution of nicotinic acid which was arbitrarily
designated as 1.
3. Water/Ether Partition (Joefflcient8
Procedure: A known amount of nicotinate was
added to a mixture of equal parts of ether and
water. After shaking, aliquots of ether and water
were taken for determination of nicotinic acid
after hydrolysis in excess 0.1 N NaOH. Titration
with a standard acid (.1 N HC1) was carried out
to determine the amount of alkali remaining
following hydrolysis. From this the number of
milliequivalents of nicotinate dissolved in 25 ml.
samples of water and ether was calculated and the
partition coefficient derived.
Re8ults: The water/ether partition coefficients
are given in Table III.
4. Absolute Solubilities in Water an4 Ether
Procedure: Water and ether were saturated with
excess amounts of the various nicotinates. Each
solution was placed on a magnet mixer for two
days to ensure saturation. Care was taken to avoid
evaporation. One ml. samples were taken of each
saturated solution and titrated according to the
procedure described in section 3. A compound was
considered greater than 50% soluble when 1 ml.
or 1 gin, of a liquid or solid substance respectively
would dissolve in 1 ml. of ether or water.
Results: The absolute solubiities in water and
ether are shown in Table IV.
TABLE II
Topical application in 95% alcohol
(0.01 ml.)
End Points Penetration
Nicotinic Acid 1:150 1
Nicotinic Acid HC1 1:150 1
Methyl Nicotinate 1:20000 133
Ethyl Nicotinate 1:18000 120
Butyl Nicotinate 1:2700 18
Hexyl Nicotinate 1:4.000 27
Octyl Nicotinate 1:300 2
Tetrahydrofurfuryl Nico-
tinate 1:4300 29
* Minimal concentrations giving erythema.
t Relative concentrations giving erythema.
TABLE III
Water ether partition coefficients
Nicotinic Acid
Nicotinic Acid HCI
Methyl Nicotinate
Ethyl Nicotinate
Butyl Nicotinate
Hexyl Nicotinate
Octyl Nicotinate
Tetrahydrofurfuryl Nicotinate
9.25
45.4
.373
.136
.028
.012
.032
.394
TABLE IV
Absolute solubilities
Ab. Sol. H,0 Ab. SoL Ethert
Nicotinic Acid
Nicotinic Acid HC1.
Methyl Nicotinate..
Ethyl Nicotinate....
Butyl Nicotinate....
Hexyl Nicotinate. ..
OctylNicotinate....
Tetrahydrofurfuryl
Nicotinate
24.7 mg/ml
304.2 mg/mi
>50%
45.9 mg/mi
10.7 mg/mi
4.9 mg/mI
2.1 mg/nil
>50%
1.1 mg/mI
.4 mg/mI
>50%
>50%
>50%
>50%
>50%
>50%
* Absolute solubility in water.
t Absolute solubility in ether.
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TABLE V
Summary of Findings
Penetration W/EPart. Ab. Sol. H,O Ab. Sol. Ethers
Nicotinic Acid 1 9.25 24.7 mg/mi 1.1 mg/mi
Nicotinic Acid HC1 1 45.4 304.2 mg/mi .4 mg/mi
Methyl Nicotinate 133 .373 >50% >50%
Ethyl Nicotinate 120 .136 45.9 mg/mI >50%
Butyl Nicotinate 18 .028 10.7 mg/mi >50%
Hexyi Nicotinate 27 .012 4.9 mg/mi >50%
Octyl Nlcotinate 2 .032 2.1 mg/mi >50%
Tetrahydrofurfuryi Nicotinate 29 .394 >50% >50%
* Relative rates of penetration.
f Water/ether partition coefficient.
Absolute solubility in water.
* Absolute solubility in ether.
DISCUSSION
The lipid theory of Meyer and Overton regard-
ing percutaneous absorption was proposed 35
years ago (15). Subsequent modifications such as
the mosaic theory and the importance of the
water/ether partition co-efficient have not
drastically altered the original postulate that it is
the ratio of the solubiities in water and lipid
that is important in enhancing percutaneous
absorption.
Although this theory and its modifications are
widely accepted there has been relatively little
direct experimental evidence to support it.
Technical difficulties are formidable. Most
workers since the introduction of radioactive or
tagged compounds have employed electrolytes.
Their studies have confirmed the impression that
the epidermis is relatively impermeable to these
substances. One study by Treherne (16), who
used an in vitro system and C'4 and 535 labelled
non-electrolytes, does support the concept of the
importance of the water/ether partition co-
efficient. Another by Valette (17) indicates that
viscosity as well as liposolubiity is of importance.
Hence, for a series of related non-electrolytes with
similar partition coefficients, penetration will be
greatest when a certain optimum chain length
exists. In his series this ranged between 6 and 9
carbon atoms.
Our work was undertaken for two reasons.
First, to develop the biologic method of studying
percutaneous absorption to a practical level;
second, in the hope of adding further proof or
disproof to the Meyer-Overton concept. It was
felt that a related series of biologically active
substances with varying water/ether solubilities
would be useful in this endeavor. Accordingly,
nicotinic acid and 7 derivatives were obtained
and studied by the methods outlined. All of the
derivatives proved active at equal concentrations
on intradermal injection (Table I).
Topical applications (Table II) show a wide
variation in percutaneous absorption and produce
consistent, measurable, biologic response as
evidenced by vasodilation (erythema). The
correlation of ability to penetrate with relatively
good solubiities in both water and ether (Table
V) is of sufficient degree to support our present
concept of the importance of this factor in the
regulation of percutaneous absorption.
SUMMARY
Nicotinic acid and 7 derivatives are compared
regarding percutaneous absorption and solubility
characteristics. Ability of these compounds to
penetrate into the coriuni (percutaneous absorp-
tion) seems related to their relative and absolute
solubilities in water and ether.
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DISCUSSION
Da. FREDERICK D. MALKINSON (Chicago, Ill.):
I think it was an old observation of Spies that
there are regional differences in the skin's
response to nicotirdc acid. The "blush" areas of
the ears, face, neck and upper chest showed the
most pronounced erythema from this compound.
Because there seem to be anatomic variations in
the skin's threshold for response I wonder if
the authors have found more rapid vasodilation
in these sites than in others.
As a further comment I would like to add that
there have been no extensive studies of changes
in percutaneous absorption in specific skin dis-
orders. Illig showed some time ago that in patients
with atopic dermatitis the skin responds para-
doxically to the application of iiicotinic acid and
its esters with vasoconstriction rather than
vasodilatation. The work that Dr. Stoughton
and his colleagues have carried out could be
logically extended to study the extent of increased
permeability of the skin -if any -in such patients.
PRESIDENT FITZPATRICK (Boston, Mass.):
Do you know anything about the mechanism of
action of these chemicals on the blood vessels?
What is the chemical basis of their effect?
DR. WILLIAM CLENDENNING (in closing): I
would like to thank the discussers.
In answer to Dr. Malkinson, we feel that it
will be interesting to investigate different areas
of the body with regard to variation in absorp-
tion and we are planning to do this in the im-
mediate future.
In answer to Dr. Fitzpatrick, we have not
done this ourselves, but Fulton, Faber and
Moreci (1) have studied the action of nicotinates
and found there is both a direct action on the
blood vessel wall and also a local nerve conduction
mechanism.
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